NASDAQ:LIVN LivaNova - LIVN Stock Forecast, Price & News Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding LivaNova PLC Please log in to your account or sign up in order to add this asset to your watchlist. $55.68 +0.89 (+1.62%) (As of 02/7/2023 12:00 AM ET) Add Compare Share Share Today's Range$54.16▼$55.7750-Day Range$53.61▼$58.1452-Week Range$41.82▼$88.00Volume409,787 shsAverage Volume459,483 shsMarket Capitalization$2.98 billionP/E RatioN/ADividend YieldN/APrice Target$79.50 ProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial Media LivaNova MarketRank™ ForecastAnalyst RatingModerate Buy2.80 Rating ScoreUpside/Downside42.8% Upside$79.50 Price TargetShort InterestBearish4.05% of Shares Sold ShortDividend StrengthN/ASustainabilityN/ANews SentimentN/AInsider TradingSelling Shares$121,123 Sold Last QuarterProj. Earnings Growth42.20%From $1.73 to $2.46 Per ShareSee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.2.19 out of 5 starsMedical Sector362nd out of 1,029 stocksElectromedical Equipment Industry9th out of 23 stocks 3.4 Analyst's Opinion Consensus RatingLivaNova has received a consensus rating of Buy. The company's average rating score is 2.80, and is based on 4 buy ratings, 1 hold rating, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $79.50, LivaNova has a forecasted upside of 42.8% from its current price of $55.68.Amount of Analyst CoverageLivaNova has only been the subject of 2 research reports in the past 90 days. Previous Next 2.0 Short Interest Percentage of Shares Shorted4.05% of the outstanding shares of LivaNova have been sold short.Short Interest Ratio / Days to CoverLivaNova has a short interest ratio ("days to cover") of 5.1.Change versus previous monthShort interest in LivaNova has recently increased by 3.83%, indicating that investor sentiment is decreasing. Previous Next 0.0 Dividend Strength Dividend YieldLivaNova does not currently pay a dividend.Dividend GrowthLivaNova does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for LIVN. Previous Next 1.2 News and Social Media Coverage News SentimentLivaNova has a news sentiment score of 0.20. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.47 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 1 news article for LivaNova this week, compared to 2 articles on an average week. Previous Next 2.5 Company Ownership Insider Buying vs. Insider SellingIn the past three months, LivaNova insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $121,123.00 in company stock.Percentage Held by InsidersOnly 0.38% of the stock of LivaNova is held by insiders.Percentage Held by Institutions98.89% of the stock of LivaNova is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 1.9 Earnings and Valuation Earnings GrowthEarnings for LivaNova are expected to grow by 42.20% in the coming year, from $1.73 to $2.46 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of LivaNova is -31.82, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of LivaNova is -31.82, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioLivaNova has a P/B Ratio of 2.29. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About LivaNova (NASDAQ:LIVN) StockLivaNova Plc is a global medical technology company, which engages in the development and delivery of therapeutic solutions for the benefit of patients, healthcare professionals, and healthcare systems. It operates through the Cardiovascular and Neuromodulation segments. The Cardiovascular segment develops, produces, and sells cardiopulmonary products, heart valves, and circulatory support products. The Neuromodulation segment designs, develops, and markets Neuromodulation therapy for the treatment of drug-resistant epilepsy, difficult-to-treat depression (DTD), and obstructive sleep apnea. The company was founded in 1987 and is headquartered in London, the United Kingdom.Read More Receive LIVN Stock News and Ratings via Email Sign-up to receive the latest news and ratings for LivaNova and its competitors with MarketBeat's FREE daily newsletter. Email Address LIVN Stock News HeadlinesJanuary 7, 2023 | finance.yahoo.comEstimating The Intrinsic Value Of LivaNova PLC (NASDAQ:LIVN)December 15, 2022 | finance.yahoo.comShareholders in LivaNova (NASDAQ:LIVN) are in the red if they invested five years agoFebruary 7, 2023 | Wall Street Watch Dogs (Ad)A gold storm is coming…“We are in the early stages of a mania – the calm before the storm.”...November 24, 2022 | finance.yahoo.comShould You Think About Buying LivaNova PLC (NASDAQ:LIVN) Now?November 7, 2022 | finance.yahoo.comLivaNova (NASDAQ:LIVN) Is Experiencing Growth In Returns On CapitalNovember 2, 2022 | finance.yahoo.comLivaNova Reports Third-Quarter 2022 ResultsOctober 26, 2022 | finance.yahoo.comLivaNova (LIVN) Expected to Beat Earnings Estimates: Should You Buy?October 21, 2022 | finance.yahoo.comBreakeven Is Near for LivaNova PLC (NASDAQ:LIVN)February 7, 2023 | Wall Street Watch Dogs (Ad)A gold storm is coming…“We are in the early stages of a mania – the calm before the storm.”...October 19, 2022 | globenewswire.comVentricular Assist Devices Market Report (2022 to 2030) - Abiomed, Inc., Medtronic Plc, Abbott Laboratories, LivaNova PLC, Boston Scientific Corporation and Jarvik Heart, Inc - GlobeNewswireOctober 13, 2022 | seekingalpha.comLivaNova Loses Profit Momentum On Higher R&D Expense (NASDAQ:LIVN) - Seeking AlphaOctober 6, 2022 | finance.yahoo.comGlobal Heart Lung Machine Market Report to 2031 - Industry Analysis, Size, Share, Growth, Trends, and Forecasts - Yahoo FinanceOctober 6, 2022 | globenewswire.comWith 5.3% CAGR, Defibrillator Market Size worth USD - GlobeNewswireOctober 5, 2022 | globenewswire.comAt 5.6% CAGR, Global Medical Perfusion Technology Market Size to Hit USD 905.50 Million by 2026: Facts & Factors - GlobeNewswireSeptember 30, 2022 | nasdaq.com21%of this LivaNova PLC (NASDAQ:LIVN) insider's holdings were sold in the last year - NasdaqSeptember 30, 2022 | benzinga.comFDA Says Livanova Recalls Lifesparc System For Risk Of Unintentional Extended Pump Stop During Controller - BenzingaSeptember 30, 2022 | seekingalpha.comFDA labels recall of blood bypass pump systems by LivaNova as most serious - Seeking AlphaSeptember 30, 2022 | nasdaq.comLivaNova Enters Oversold Territory (LIVN)September 27, 2022 | finance.yahoo.comNeuromodulation Devices Global Market - Forecast To 2029 - Yahoo FinanceSeptember 26, 2022 | benzinga.comWorldwide Heart Lung Machine Industry to 2031 - Featuring Hemovent, LivaNova, Medtronic and Nipro Among O - BenzingaSeptember 16, 2022 | finance.yahoo.comOutlook on the Endoscopic Vessel Harvesting System Global Market to 2027 - Growing Healthcare Market Presents Opportunities - Yahoo FinanceSeptember 14, 2022 | bizjournals.com2022 Fire Awards, Exits of the Year: ALung Technologies - The Business JournalsSeptember 12, 2022 | finance.yahoo.comInternal Neurostimulation Devices Market is Thriving at CAGR Of +17.4% by 2029, Size, Share, Emerging Trends, Historic Analysis, Competitive Landscape and Industry Growth Factors - Yahoo FinanceSeptember 8, 2022 | bizjournals.comCarlson Center's small neighbors sign new tenants, including Roers Cos. - The Business JournalsAugust 26, 2022 | nasdaq.comSlowing Rates Of Return At LivaNova (NASDAQ:LIVN) Leave Little Room For Excitement - NasdaqAugust 24, 2022 | reuters.comLIVN.O - LivaNova PLC | Stock Price & Latest News | ReutersAugust 18, 2022 | nasdaq.comSum Up The Parts: IVOO Could Be Worth $200 - NasdaqSee More Headlines View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart Receive LIVN Stock News and Ratings via Email Sign-up to receive the latest news and ratings for LivaNova and its competitors with MarketBeat's FREE daily newsletter. Email Address LIVN Company Calendar Last Earnings11/03/2021Today2/07/2023Next Earnings (Confirmed)2/22/2023Fiscal Year End12/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ Industry Electromedical equipment Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:LIVN CUSIPN/A CIK1639691 Webwww.livanova.com Phone442033250660Fax281-218-9332Employees3,000Year FoundedN/APrice Target and Rating Average Stock Price Forecast$79.50 High Stock Price Forecast$96.00 Low Stock Price Forecast$62.00 Forecasted Upside/Downside+42.8%Consensus RatingModerate Buy Rating Score (0-4)2.80 Research Coverage5 Analysts Profitability EPS (Most Recent Fiscal Year)($1.75) Trailing P/E RatioN/A Forward P/E Ratio32.18 P/E GrowthN/ANet Income$-135,820,000.00 Net Margins-9.14% Pretax Margin-8.24% Return on Equity9.28% Return on Assets5.07% Debt Debt-to-Equity Ratio0.45 Current Ratio2.96 Quick Ratio2.53 Sales & Book Value Annual Sales$1.04 billion Price / Sales2.88 Cash Flow$3.44 per share Price / Cash Flow16.17 Book Value$24.32 per share Price / Book2.29Miscellaneous Outstanding Shares53,520,000Free Float53,320,000Market Cap$2.98 billion OptionableOptionable Beta0.82 Key ExecutivesDamien McDonaldChief Executive Officer & Executive DirectorStephanie BoltonPresident-InternationalAlex ShvartsburgChief Financial OfficerKeyna P. SkeffingtonSecretary, Senior Vice President & General CounselMichael David HutchinsonChief Legal Officer & Senior Vice PresidentKey CompetitorsInModeNASDAQ:INMDCONMEDNYSE:CNMDTransMedics GroupNASDAQ:TMDXOutset MedicalNASDAQ:OMBioLife SolutionsNASDAQ:BLFSView All CompetitorsInsiders & InstitutionsEnvestnet Asset Management Inc.Sold 4,938 shares on 2/7/2023Ownership: 0.071%Retirement Systems of AlabamaBought 27,545 shares on 2/6/2023Ownership: 0.349%Pacer Advisors Inc.Bought 7,965 shares on 2/6/2023Ownership: 0.019%Western Pacific Wealth Management LPBought 380 shares on 2/3/2023Ownership: 0.002%ProShare Advisors LLCBought 1,355 shares on 2/2/2023Ownership: 0.019%View All Insider TransactionsView All Institutional Transactions LIVN Stock - Frequently Asked Questions Should I buy or sell LivaNova stock right now? 5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for LivaNova in the last twelve months. There are currently 1 hold rating and 4 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" LIVN shares. View LIVN analyst ratings or view top-rated stocks. What is LivaNova's stock price forecast for 2023? 5 Wall Street analysts have issued 12-month target prices for LivaNova's stock. Their LIVN share price forecasts range from $62.00 to $96.00. On average, they expect the company's share price to reach $79.50 in the next year. This suggests a possible upside of 44.2% from the stock's current price. View analysts price targets for LIVN or view top-rated stocks among Wall Street analysts. How have LIVN shares performed in 2023? LivaNova's stock was trading at $55.54 at the beginning of the year. Since then, LIVN stock has decreased by 0.7% and is now trading at $55.14. View the best growth stocks for 2023 here. When is LivaNova's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Wednesday, February 22nd 2023. View our LIVN earnings forecast. How can I listen to LivaNova's earnings call? LivaNova will be holding an earnings conference call on Wednesday, February 22nd at 8:00 AM Eastern. Interested parties can register for or listen to the call using this link. How were LivaNova's earnings last quarter? LivaNova PLC (NASDAQ:LIVN) released its quarterly earnings data on Wednesday, November, 3rd. The company reported $0.68 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.45 by $0.23. The company earned $253.20 million during the quarter, compared to analysts' expectations of $245.24 million. LivaNova had a positive trailing twelve-month return on equity of 9.28% and a negative net margin of 9.14%. The business's revenue for the quarter was up 5.5% compared to the same quarter last year. During the same period in the prior year, the business earned $0.38 EPS. What guidance has LivaNova issued on next quarter's earnings? LivaNova updated its FY 2022 earnings guidance on Wednesday, November, 9th. The company provided earnings per share guidance of $2.25-$2.45 for the period, compared to the consensus EPS estimate of $2.30. The company issued revenue guidance of $1.08 billion-$1.10 billion, compared to the consensus revenue estimate of $1.01 billion. What is Damien McDonald's approval rating as LivaNova's CEO? 47 employees have rated LivaNova Chief Executive Officer Damien McDonald on Glassdoor.com. Damien McDonald has an approval rating of 77% among the company's employees. What other stocks do shareholders of LivaNova own? Based on aggregate information from My MarketBeat watchlists, some companies that other LivaNova investors own include BioTelemetry (BEAT), Occidental Petroleum (OXY), Pfizer (PFE), Amarin (AMRN), Genocea Biosciences (GNCA), AbbVie (ABBV), Abbott Laboratories (ABT), ACADIA Pharmaceuticals (ACAD), Chipotle Mexican Grill (CMG) and CRISPR Therapeutics (CRSP). What is LivaNova's stock symbol? LivaNova trades on the NASDAQ under the ticker symbol "LIVN." Who are LivaNova's major shareholders? LivaNova's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Sumitomo Mitsui Trust Holdings Inc. (1.64%), Allspring Global Investments Holdings LLC (1.46%), Retirement Systems of Alabama (0.35%), Bank of Montreal Can (0.27%), Comerica Bank (0.12%) and New York State Teachers Retirement System (0.12%). Insiders that own company stock include Alfred J Novak, Damien Mcdonald, Daniel Jeffrey Moore and Marco Dolci. View institutional ownership trends. How do I buy shares of LivaNova? Shares of LIVN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is LivaNova's stock price today? One share of LIVN stock can currently be purchased for approximately $55.14. How much money does LivaNova make? LivaNova (NASDAQ:LIVN) has a market capitalization of $2.95 billion and generates $1.04 billion in revenue each year. The company earns $-135,820,000.00 in net income (profit) each year or ($1.75) on an earnings per share basis. How many employees does LivaNova have? The company employs 3,000 workers across the globe. How can I contact LivaNova? LivaNova's mailing address is 20 EASTBOURNE TERRACE, LONDON X0, W2 6LG. The official website for the company is www.livanova.com. The company can be reached via phone at 442033250660, via email at investor.relations@livanova.com, or via fax at 281-218-9332. This page (NASDAQ:LIVN) was last updated on 2/7/2023 by MarketBeat.com Staff Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.